143 related articles for article (PubMed ID: 37245855)
1. Psychometric properties of the Treatment Effectiveness Assessment in methamphetamine use disorder.
Vo HT; Kulikova A; Mayes TL; Carmody T; Shoptaw S; Ling W; Trombello JM; Trivedi MH
J Subst Use Addict Treat; 2023 Aug; 151():209085. PubMed ID: 37245855
[TBL] [Abstract][Full Text] [Related]
2. Psychometrics of the Concise Health Risk Tracking Self-Report (CHRT-SR
Trombello JM; Kulikova A; Mayes TL; Nandy K; Carmody T; Bart G; Nunes EV; Schmitz J; Kalmin M; Shoptaw S; Trivedi MH
Neuropsychiatr Dis Treat; 2023; 19():1443-1454. PubMed ID: 37377462
[TBL] [Abstract][Full Text] [Related]
3. A psychometric evaluation of the Concise Health Risk Tracking Self-Report (CHRT-SR)- a measure of suicidality-in patients with stimulant use disorder.
Sanchez K; Killian MO; Mayes TL; Greer TL; Trombello JM; Lindblad R; Grannemann BD; Carmody TJ; Rush AJ; Walker R; Trivedi MH
J Psychiatr Res; 2018 Jul; 102():65-71. PubMed ID: 29626753
[TBL] [Abstract][Full Text] [Related]
4. Measuring recovery in opioid use disorder: clinical utility and psychometric properties of the Treatment Effectiveness Assessment.
Ling W; Nadipelli VR; Solem CT; Farabee D; Ronquest NA; Perrochet B; Learned SM; Deshpande CG; Heidbreder C
Subst Abuse Rehabil; 2019; 10():13-21. PubMed ID: 31239805
[No Abstract] [Full Text] [Related]
5. Development and psychometric properties of the methamphetamine decisional balance scale (METH-DBS) for young adults.
Khazaee-Pool M; Jahangiry L; Pashaei T; Ramezani-Badr F; Nadrian H; Ponnet K
Subst Abuse Treat Prev Policy; 2018 Oct; 13(1):38. PubMed ID: 30373625
[TBL] [Abstract][Full Text] [Related]
6. Psychometric properties of the 7-item version of the Concise Health Risk Tracking Self-Report Scale for rural adults enrolled in an Internet-delivered self-help program for depression.
Weissman RS; Scott BG; Schure MB; McCrory B; Greist J; Kuntz M; Wilcox HC
J Rural Health; 2022 Jun; 38(3):574-582. PubMed ID: 34643960
[TBL] [Abstract][Full Text] [Related]
7. Psychometric evaluation of the 9-item Concise Health Risk Tracking - Self-Report (CHRT-SR
Nandy K; Rush AJ; Slater H; Mayes TL; Minhajuddin A; Jha M; Blader JC; Brown R; Emslie G; Fuselier MN; Garza C; Gushanas K; Kennard B; Storch EA; Wakefield SM; Trivedi MH
J Affect Disord; 2023 May; 329():548-556. PubMed ID: 36806661
[TBL] [Abstract][Full Text] [Related]
8. The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorder.
Brown ES; Murray M; Carmody TJ; Kennard BD; Hughes CW; Khan DA; Rush AJ
Ann Allergy Asthma Immunol; 2008 May; 100(5):433-8. PubMed ID: 18517074
[TBL] [Abstract][Full Text] [Related]
9. Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.
Fokkens W; Trigg A; Lee SE; Chan RH; Diamant Z; Hopkins C; Howarth P; Lund V; Mayer B; Sousa AR; Yancey S; Tabberer M;
J Patient Rep Outcomes; 2023 Jan; 7(1):4. PubMed ID: 36662344
[TBL] [Abstract][Full Text] [Related]
10. Psychometric Evaluation of the MENQOL Instrument in Women Experiencing Vasomotor Symptoms Associated with Menopause.
Schultz NM; Morga A; Siddiqui E; Rhoten SE
Adv Ther; 2024 Jun; 41(6):2233-2252. PubMed ID: 38396203
[TBL] [Abstract][Full Text] [Related]
11. Reliability and construct validity of 3 psychometric trust scales for women seeking substance abuse treatment in a community setting.
Cockroft JD; Adams SM; Matlock D; Dietrich MS
Subst Abus; 2020; 41(3):391-399. PubMed ID: 31368857
[No Abstract] [Full Text] [Related]
12. [Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population].
Zanello A; Weber Rouget B; Gex-Fabry M; Maercker A; Guimon J
Encephale; 2006; 32(1 Pt 1):45-59. PubMed ID: 16633290
[TBL] [Abstract][Full Text] [Related]
13. Development of a social inclusion index to capture subjective and objective life domains (Phase II): psychometric development study.
Huxley P; Evans S; Madge S; Webber M; Burchardt T; McDaid D; Knapp M
Health Technol Assess; 2012; 16(1):iii-vii, ix-xii, -1-241. PubMed ID: 22260923
[TBL] [Abstract][Full Text] [Related]
14. A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR).
Ostacher MJ; Nierenberg AA; Rabideau D; Reilly-Harrington NA; Sylvia LG; Gold AK; Shesler LW; Ketter TA; Bowden CL; Calabrese JR; Friedman ES; Iosifescu DV; Thase ME; Leon AC; Trivedi MH
J Psychiatr Res; 2015 Dec; 71():126-33. PubMed ID: 26476489
[TBL] [Abstract][Full Text] [Related]
15. Construct validity of the items on the Stroke Specific Quality of Life (SS-QOL) questionnaire that evaluate the participation component of the International Classification of Functioning, Disability and Health.
Silva SM; Corrêa FI; Pereira GS; Faria CDCM; Corrêa JCF
Disabil Rehabil; 2018 Jan; 40(2):225-231. PubMed ID: 27830956
[TBL] [Abstract][Full Text] [Related]
16. The Short Barriers Questionnaire (SBQ): Validity, factor structure and correlates in an out-of-treatment sample of people dependent on methamphetamine.
McKetin R; Voce A; Burns RA; Quinn B
J Subst Abuse Treat; 2020 Sep; 116():108029. PubMed ID: 32741495
[TBL] [Abstract][Full Text] [Related]
17. Validity and reliability of a Nigerian-Yoruba version of the stroke-specific quality of life scale 2.0.
Odetunde MO; Akinpelu AO; Odole AC
Health Qual Life Outcomes; 2017 Oct; 15(1):205. PubMed ID: 29052510
[TBL] [Abstract][Full Text] [Related]
18. Preliminary Psychometric Evaluation of the Hamilton Depression Rating Scale in Methamphetamine Dependence.
Hellem T; Scholl L; Sung YH; Ferguson H; McGlade E; Yurgelun-Todd D; Renshaw P; Hildreth L
J Dual Diagn; 2017; 13(4):305-311. PubMed ID: 28820669
[TBL] [Abstract][Full Text] [Related]
19. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.
Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
Clin Ther; 2007 May; 29(5):950-962. PubMed ID: 17697914
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in Iranian patients with bipolar disorder: a psychometric study of the Persian Brief Quality of Life in Bipolar Disorder (QoL.BD).
Modabbernia A; Yaghoubidoust M; Lin CY; Fridlund B; Michalak EE; Murray G; Pakpour AH
Qual Life Res; 2016 Jul; 25(7):1835-44. PubMed ID: 26714698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
